Colchicine in cardiac disease: A systematic review and meta-analysis of randomized controlled trials

BMC Cardiovascular Disorders

Volumn 15, Issue 1, 2015, Pages

  Verma, Subodh ^a,b   Eikelboom, John W ^c   Nidorf, Stefan M ^d   Al Omran, Mohammed ^a,b   Gupta, Nandini ^c   Teoh, Hwee ^a   Friedrich, Jan O ^a,b  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c MCMASTER UNIVERSITY   (Canada)

^d HEART RESEARCH INSTITUTE   (Australia)

Author keywords

Cardiovascular disease; Colchicine; Meta analysis

Indexed keywords

COLCHICINE; PLACEBO;

ACUTE CORONARY SYNDROME; ARTICLE; ATRIAL FIBRILLATION; CEREBROVASCULAR ACCIDENT; CONGESTIVE HEART FAILURE; CORONARY ARTERY DISEASE; DIARRHEA; DRUG DOSE REDUCTION; DRUG HYPERSENSITIVITY; DRUG WITHDRAWAL; DYSPEPSIA; GASTROINTESTINAL SYMPTOM; HEART DISEASE; HEART INFARCTION; HUMAN; META ANALYSIS; MORTALITY; NAUSEA; PERICARDITIS; POSTPERICARDIOTOMY SYNDROME; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTEMATIC REVIEW; HEART DISEASES; PROCEDURES;

COLCHICINE; HEART DISEASES; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84940034681     PISSN: None     EISSN: 14712261     Source Type: Journal    
DOI: 10.1186/s12872-015-0068-3     Document Type: Article

References (45)

1. Terkeltaub RA, Furst DE, Bennett K, Kook KA, Crockett RS, Davis MW. High versus low dosing of oral colchicine for early acute gout flare: Twenty-four-hour outcome of the first multicenter, randomized, double-blind, placebo-controlled, parallel-group, dose-comparison colchicine study. Arthritis Rheum. 2010;62:1060-8.
2. Ben-Chetrit E, Levy M. Colchicine prophylaxis in familial Mediterranean fever: reappraisal after 15 years. Semin Arthritis Rheum. 1991;20:241-6.
3. Bhat A, Naguwa SM, Cheema GS, Gershwin ME. Colchicine revisited. Ann N Y Acad Sci. 2009;1173:766-73.
4. Zemer D, Livneh A, Danon YL, Pras M, Sohar E. Long-term colchicine treatment in children with familial Mediterranean fever. Arthritis Rheum. 1991;34:973-7.
5. Evereklioglu C. Current concepts in the etiology and treatment of Behcet disease. Surv Ophthalmol. 2005;50:297-350.
6. Yurdakul S, Mat C, Tuzun Y, Ozyazgan Y, Hamuryudan V, Uysal O, et al. A double-blind trial of colchicine in Behcet's syndrome. Arthritis Rheum. 2001;44:2686-92.
7. Deftereos S, Giannopoulos G, Papoutsidakis N, Panagopoulou V, Kossyvakis C, Raisakis K, et al. Colchicine and the heart: pushing the envelope. J Am Coll Cardiol. 2013;62:1817-25.
8. Nidorf SM, Eikelboom JW, Thompson PL. Targeting cholesterol crystal-induced inflammation for the secondary prevention of cardiovascular disease. J Cardiovasc Pharmacol Ther. 2014;19:45-52.
9. Verma S, Gupta M, Ridker PM. Therapeutic targeting of inflammation in atherosclerosis: we are getting closer. Can J Cardiol. 2012;28:619-22.
10. Haynes RB, McKibbon KA, Wilczynski NL, Walter SD, Werre SR, Hedges T. Optimal search strategies for retrieving scientifically strong studies of treatment from Medline: analytical survey. BMJ. 2005;330:1179.
11. Wong SS, Wilczynski NL, Haynes RB. Developing optimal search strategies for detecting clinically sound treatment studies in EMBASE. J Med Libr Assoc. 2006;94:41-7.
12. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177-88.
13. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557-60.
14. Nidorf SM, Eikelboom JW, Budgeon CA, Thompson PL. Low-dose colchicine for secondary prevention of cardiovascular disease. J Am Coll Cardiol. 2013;61:404-10.
15. Raju NC, Yi Q, Nidorf M, Fagel ND, Hiralal R, Eikelboom JW. Effect of colchicine compared with placebo on high sensitivity C-reactive protein in patients with acute coronary syndrome or acute stroke: a pilot randomized controlled trial. J Thromb Thrombolysis. 2012;33:88-94.
16. O'Keefe Jr JH, McCallister BD, Bateman TM, Kuhnlein DL, Ligon RW, Hartzler GO. Ineffectiveness of colchicine for the prevention of restenosis after coronary angioplasty. J Am Coll Cardiol. 1992;19:1597-600.
17. Deftereos S, Giannopoulos G, Panagopoulou V, Bouras G, Raisakis K, Kossyvakis C, et al. Anti-inflammatory treatment with colchicine in stable chronic heart failure: a prospective, randomized study. JACC Heart Fail. 2014;2:131-7.
18. Imazio M, Bobbio M, Cecchi E, Demarie D, Demichelis B, Pomari F, et al. Colchicine in addition to conventional therapy for acute pericarditis: results of the COlchicine for acute PEricarditis (COPE) trial. Circulation. 2005;112:2012-6.
19. Imazio M, Brucato A, Cemin R, Ferrua S, Maggiolini S, Beqaraj F, et al. A randomized trial of colchicine for acute pericarditis. N Engl J Med. 2013;369:1522-8.
20. Imazio M, Bobbio M, Cecchi E, Demarie D, Pomari F, Moratti M, et al. Colchicine as first-choice therapy for recurrent pericarditis: results of the CORE (COlchicine for REcurrent pericarditis) trial. Arch Intern Med. 2005;165:1987-91.
21. Imazio M, Brucato A, Cemin R, Ferrua S, Belli R, Maestroni S, et al. Colchicine for recurrent pericarditis (CORP): a randomized trial. Ann Intern Med. 2011;155:409-14.
22. Imazio M, Belli R, Brucato A, Cemin R, Ferrua S, Beqaraj F, et al. Efficacy and safety of colchicine for treatment of multiple recurrences of pericarditis (CORP-2): a multicentre, double-blind, placebo-controlled, randomised trial. Lancet. 2014;383:2232-7.
23. Finkelstein Y, Shemesh J, Mahlab K, Abramov D, Bar-El Y, Sagie A, et al. Colchicine for the prevention of postpericardiotomy syndrome. Herz. 2002;27:791-4.
24. Imazio M, Trinchero R, Brucato A, Rovere ME, Gandino A, Cemin R, et al. COlchicine for the Prevention of the Post-pericardiotomy Syndrome (COPPS): a multicentre, randomized, double-blind, placebo-controlled trial. Eur Heart J. 2010;31:2749-54.
25. Imazio M, Brucato A, Ferrazzi P, Pullara A, Adler Y, Barosi A, et al. Colchicine for Prevention of Postpericardiotomy Syndrome and Postoperative Atrial Fibrillation: The COPPS-2 Randomized Clinical Trial. JAMA. 2014;312(10):1016-23.
26. Sarzaeem M, Shayan N, Bagheri J, Jebelli M, Mandegar M. Low dose colchicine in prevention of atrial fibrillation after coronary artery bypass graft: a double blind clinical trial. Tehran Univ Med J. 2014;72:147-54.
27. Deftereos S, Giannopoulos G, Kossyvakis C, Efremidis M, Panagopoulou V, Kaoukis A, et al. Colchicine for prevention of early atrial fibrillation recurrence after pulmonary vein isolation: a randomized controlled study. J Am Coll Cardiol. 2012;60:1790-6.
28. Imazio M, Brucato A, Ferrazzi P, Rovere ME, Gandino A, Cemin R, et al. Colchicine reduces postoperative atrial fibrillation: results of the Colchicine for the Prevention of the Postpericardiotomy Syndrome (COPPS) atrial fibrillation substudy. Circulation. 2011;124:2290-5.
29. Deftereos S, Giannopoulos G, Efremidis M, Kossyvakis C, Katsivas A, Panagopoulou V, et al. Colchicine for prevention of atrial fibrillation recurrence after pulmonary vein isolation: mid-term efficacy and effect on quality of life. Heart Rhythm. 2014;11:620-8.
30. Imazio M, Brucato A, Markel G, Cemin R, Trinchero R, Spodick DH, et al. Meta-analysis of randomized trials focusing on prevention of the postpericardiotomy syndrome. Am J Cardiol. 2011;108:575-9.
31. Imazio M, Brucato A, Belli R, Forno D, Ferro S, Trinchero R, et al. Colchicine for the prevention of pericarditis: what we know and what we do not know in 2014 - systematic review and meta-analysis. J Cardiovasc Med (Hagerstown). 2014;15:840-6.
32. Imazio M, Brucato A, Forno D, Ferro S, Belli R, Trinchero R, et al. Efficacy and safety of colchicine for pericarditis prevention. Systematic review and meta-analysis. Heart. 2012;98:1078-82.
33. Lotrionte M, Biondi-Zoccai G, Imazio M, Castagno D, Moretti C, Abbate A, et al. International collaborative systematic review of controlled clinical trials on pharmacologic treatments for acute pericarditis and its recurrences. Am Heart J. 2010;160:662-70.
34. Alabed S, Cabello JB, Irving GJ, Qintar M, Burls A. Colchicine for pericarditis. Cochrane Database Syst Rev. 2014;8:CD010652.
35. Hemkens LG, Gloy VL, Olu KK, Nordmann AJ, Briel M. Colchicine for prevention of cardiovascular events. Cochrane Database Syst Rev. 2014;3:CD011047.
36. Nidorf SM, Eikelboom JW, Thompson PL. Colchicine for secondary prevention of cardiovascular disease. Curr Atheroscler Rep. 2014;16:391.
37. Ridker PM, Luscher TF. Anti-inflammatory therapies for cardiovascular disease. Eur Heart J. 2014;35:1782-91.
38. Saenen JB, Vanduynhoven PH, Pintelon I, Miljoen HPJ, Timmermans JP, Laga S, et al. Connexin lateralization during Coronary Artery Bypass Graft (CABG) operation: A target for the antiarrhythmic effect of colchicine in the prevention of post-operative atrial fibrillation. Eur Heart J. 2013;34:252-3.
39. Nidorf M, Thompson PL. Effect of colchicine (0.5 mg twice daily) on high-sensitivity C-reactive protein independent of aspirin and atorvastatin in patients with stable coronary artery disease. Am J Cardiol. 2007;99:805-7.
40. Freed M, Safian RD, O'Neill WW, Safian M, Jones D, Grines CL. Combination of lovastatin, enalapril, and colchicine does not prevent restenosis after percutaneous transluminal coronary angioplasty. Am J Cardiol. 1995;76:1185-8.
41. Rab ST, King 3rd SB, Roubin GS, Carlin S, Hearn JA, Douglas Jr JS. Coronary aneurysms after stent placement: a suggestion of altered vessel wall healing in the presence of anti-inflammatory agents. J Am Coll Cardiol. 1991;18:1524-8.
42. Judkins C, Thompson P. M. N., McQuillan B: LoDoCo: LOw DOse COlchicine in stable coronary artery disease and the effect on hs-CRP and brachial flow mediated dilation. Heart Lung Circ. 2011;20:S36.
43. Luo ZM, Yang L. A randomized controlled clinical trial of MgSO4 plus cyclophosphamide and colchicine in patients suffered from acute cerebral infarction. Hong Kong Med J. 2001;7:23.
44. Xu YM, Luo ZM, He L, Peng R, Zhou D. Clinical randomized controlled trial of patients with acute cerebral infarction treated with cyclophosphamide and colchicine. West China Medical J. 1999;14:23-6.
45. Liu L, Luo ZM, He L, Zhang ZL, Li ZX, Peng SZ. Multicentric randomized controlled trial of treatment of patients with acute cerebral infarction with cyclophosphamide and colchicine. Chin J Geriatric Cardiovasc Cerebrovasc Dis. 2002;4:108-11.